We are a clinical stage company focused on bringing clarity of thought to people suffering from Alzheimer's disease, traumatic brain injury, and schizophrenia.

superb scientific advisors

our approach to Pharmaceutical Drug Development

Our Mission

strategic partnerships

Tetra designs drugs to treat memory loss and cognitive impairment by improving how the brain processes and stores information.

Working with potentially breakthrough technology, our goal is to improve the quality of life in patients suffering from

  • Alzheimer's disease, 
  • other dementias,
  • traumatic brain injury,
  • major psychiatric diseases and
  • neurodevelopmental disorders.

Our Scientific Advisory Board offers talent, experience, and a vision for new medicines.

Tetra's promising drug for Alzheimer's disease is being developed in partnership with the NIH Blueprint Therapeutics program.

Follow Tetra on Social Media

For information and to inquire about participating in Tetra clinical trials, please click here.



innovative science

The drugs in our pipeline offer a new mechanism focused on PDE4B and PDE4D.​

Participating in TETRA Clinical Trials